Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

NiV&HeV: A New Era of Structure-based Vaccine Design? Nipah virus (NiV ... By utilizing ACROBiosystems’ advanced reagents, researchers can achieve optimal results in vaccine development with antigens ...

This advanced MVA manufacturing process is expected to significantly simplify vaccine production, particularly in middle- and low-income regions where supply chain issues often hinder access to ...